Daiwa Securities Group’s Seres Therapeutics MCRB Stock Holding History

Daiwa Securities Group’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25	Closed	-$1K	–	1363
2023 Q3	$1K	Hold	25	–	–	﹤0.01%	1260
2023 Q2	$2K	Hold	25	–	–	﹤0.01%	1238
2023 Q1	$3K	Hold	25	–	–	﹤0.01%	1191
2022 Q4	$3K	Buy	25 +9	+56%	+$1.21K	﹤0.01%	1200
2022 Q3	$2K	Hold	16	–	–	﹤0.01%	1235
2022 Q2	$1K	Hold	16	–	–	﹤0.01%	1300
2022 Q1	$2K	Hold	16	–	–	﹤0.01%	1258
2021 Q4	$3K	Hold	16	–	–	﹤0.01%	1248
2021 Q3	$2K	Buy	16 +7	+78%	+$1.37K	﹤0.01%	1243
2021 Q2	$4K	Hold	9	–	–	﹤0.01%	1092
2021 Q1	$4K	Hold	9	–	–	﹤0.01%	1092
2020 Q4	$4K	Sell	9 -13	-59%	-$7.61K	﹤0.01%	1070
2020 Q3	$13K	Hold	22	–	–	﹤0.01%	1028
2020 Q2	$2K	Hold	22	–	–	﹤0.01%	1160
2020 Q1	$2K	Hold	22	–	–	﹤0.01%	1159
2019 Q4	$2K	Hold	22	–	–	﹤0.01%	1163
2019 Q3	$2K	Buy	22 +11	+100%	+$727	﹤0.01%	1130
2019 Q2	$1K	Hold	11	–	–	﹤0.01%	1180
2019 Q1	$2K	Hold	11	–	–	﹤0.01%	1134
2018 Q4	$1K	Hold	11	–	–	﹤0.01%	1131
2018 Q3	$2K	Hold	11	–	–	﹤0.01%	1129
2018 Q2	$2K	Hold	11	–	–	﹤0.01%	1140
2018 Q1	$2K	Buy	+11	New	+$2.11K	﹤0.01%	1129

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Daiwa Securities Group's MCRB Position: Q4 2023 in Review

Daiwa Securities Group sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 25 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in MCRB in Q1 2018 and held it in 23 quarters. The position peaked at $13K in Q3 2020. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.

Daiwa Securities Group reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
Daiwa Securities Group sold 25 Seres Therapeutics shares in Q4 2023, an estimated $1K.
Daiwa Securities Group first reported a position in Seres Therapeutics in Q1 2018 and held it in 23 quarters.
Daiwa Securities Group's Seres Therapeutics position peaked at $13K in Q3 2020.
102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.